• HOME
  • ABOUT US
    • CAREERS
  • TECHNOLOGY
  • NEWS
  • SERVICES
    • RESEARCH AND DEVELOPMENT
  • PRODUCTS
  • CONTACT
Type and hit ENTER
  • HOME
  • ABOUT US
    • CAREERS
  • TECHNOLOGY
  • NEWS
  • SERVICES
    • RESEARCH AND DEVELOPMENT
  • PRODUCTS
  • CONTACT
GET CONNECTED
  • HOME
  • ABOUT US
    • CAREERS
  • TECHNOLOGY
  • NEWS
  • SERVICES
    • RESEARCH AND DEVELOPMENT
  • PRODUCTS
  • CONTACT
ProAxsis presenting further data at COPD 11 Conference
Share
Conferences

ProAxsis presenting further data at COPD 11 Conference

June 18, 2018
-
Posted by David Ribeiro

ProAxsis will be presenting three abstracts at the COPD 11 Conference, which takes place between June 20th-21st 2018 in Birmingham, UK.  These include:

• The Development of a Novel Immunoassay for the Detection and Quantification of Murine Neutrophil Elastase (Ashleigh Kennedy)
• Sputum Storage Conditions and their Effect on the Quantification of Active Protease Biomarkers for COPD (Diane Ramsay)
• Evaluation of NEATstik® – A novel point of care test for the detection of active neutrophil elastase in sputum (Charlene Robb)

Dr David Ribeiro, CEO of ProAxsis, said: “We’re pleased to be able to share this new data with the COPD community, and look forward to continuing our ongoing collaborations with the University of Oxford, Belfast Hospital Trust and Chiesi Pharmaceuticals.”

ProAxsis is part of the NetScientific group and is one of the group’s core portfolio companies. The company is also supported by QUBIS, the commercialisation arm of Queens University Belfast.

To find out how ProAxsis can support the measurement of active protease biomarkers of disease, or for any further queries, please contact info@proaxsis.com

June 18, 2018

Related News

Other posts that you should not miss.
Conferences, News

ProAxsis CEO to present at Anglonordic Conference

May 30, 2017
-
Posted by Webmaster

Dr David Ribeiro, CEO of ProAxsis, will be attending the Anglonordic Life Sciences Conference, taking place in London …

Read More
May 30, 2017
Posted by Webmaster
Conferences, Neutrophil Elastase Immunoassay, News, ProteaseTag®

ProAxsis’ ProteaseTag® NE Immunoassay highlighted at BTS 2016

December 8, 2016
-
Posted by Webmaster

ProAxsis (www.proaxsis.com) was delighted to observe that measuring active neutrophil elastase (NE) by its ProteaseTag® Active NE Immunoassay …

Read More
December 8, 2016
Posted by Webmaster
Conferences, News

ProAxsis to present at 2016 American Thoracic Society Conference

May 16, 2016
-
Posted by Webmaster

ProAxsis will this week be presenting further data on its ProteaseTag® Active Neutrophil Elastase (NE) Immunoassay, at the American …

Read More
May 16, 2016
Posted by Webmaster
← PREVIOUS POST
ProAxsis enhances portfolio with new CE Marked Immunoassay
NEXT POST →
ProAxsis wins Innovative Business of the Year Award
Categories
  • Announcements
  • Conferences
  • NEATstik®
  • Neutrophil Elastase Immunoassay
  • News
  • ProteaseTag®
  • Trials
  • Video
GET CONNECTED
RECENT POSTS
  • ProAxsis signs global in-licensing agreement with AstraZeneca for COVID-19 serology test
    June 7, 2021

    ProAxsis Limited (www.proaxsis.com), the Belfast-based respiratory diagnostics company, is delighted to announce it …

  • ProAxsis Ltd CEO Update Report – May 2021
    May 21, 2021

    Introduction In parallel with the release of the company’s 2020 financial statements, I …

  • ProAxsis Limited enters licensing agreement with top Swiss University as it continues to develop novel new products in the fight against fractures and other metabolic bone diseases
    February 21, 2021

    ProAxsis (www.proaxsis.com), the Belfast-based diagnostics company, and a collaboration of the University of …


ProAxsis Ltd
Unit 1B, Concourse Building 3,
Catalyst Inc,
Queen’s Road, Titanic Quarter,
Belfast,
BT3 9DT,
Northern Ireland

tel +44 (0)28 9073 0444
email info@proaxsis.com

RECENT NEWS
  • May 17, 2022
    Belfast Telegraph Awards
  • May 16, 2022
    ProAxsis announces “impressive” results in Performance Evaluation of COVID-19 antibody test
  • January 31, 2022
    ProAxsis enhances availability of product portfolio in Asia via new partnership with Kyberlife
Copyright © 2016-2021 - ProAxsis - All rights reserved. 
ProAxsis presenting further data at COPD 11 Conference - ProAxsis